Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
Quick Stats
Mar 30, 202653.4
AI Score
HOLD1.22
Volume Ratio
May 05, 2026
Next Earnings
13
+ve Days (30d)
17
-ve Days (30d)
RARE Stock Summary
Last updated Mar 30, 2026
RARE is currently trading at $19.24, positioned below its 200-day moving average of $29.12, suggesting bearish momentum. The stock has a 52-week range of $18.29 to $42.37.
Technical Analysis: The 50-day moving average stands at $22.35, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 37.207, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.218, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates RARE at 53.4/100 with a HOLD recommendation.
RARE (Ultragenyx Pharmaceutical Inc.) Indicators
Last updated Mar 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 37.207 |
| CMF (20) | -0.218 |
| ROC (10) | -11.503 |
| ADX (14) | 25.745 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.93 |
| AROONOSC (14) | -71.429 |
| WILLAMS %R (14) | -77.582 |
| MFI (14) | 20.653 |
RARE Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RARE Price vs Max Options Open Interest
RARE Max Change In Options Open Interest
RARE Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RARE Daily Out of Money Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RARE Daily In the Money Options - Sort by Max open Interest (near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RARE Most Active Options by Volume(near term)
30th March 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Ultragenyx Pharmaceutical Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
RARE Moving Averages Analysis
RARE (Ultragenyx Pharmaceutical Inc.) Simple Moving Averages
Moving Averages are last updated Mar 30, 2026
| Days | MA |
|---|---|
| 10 | 19.96 |
| 20 | 20.94 |
| 30 | 21.38 |
| 50 | 22.35 |
| 100 | 26.71 |
| 200 | 29.12 |
RARE Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 1.9 billion |
| Earnings/Share ($) | -5.83 |
| Net Proft Margin (%) | -0.8544 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -4.402 |
| EPS Estimate Next Year ($) | 0.0809 |
| WallStreet Target Price ($) | 52.45 |
| Most Recent Quarter |